Literature DB >> 7102682

Stability and compatibility of lidocaine hydrochloride with selected large-volume parenterals and drug additives.

H L Kirschenbaum, W Aronoff, G P Perentesis, G W Plitz, A J Cutie.   

Abstract

The stability of lidocaine hydrochloride in six commonly used large-volume parenterals when stored for 14 days and the visual compatibility of lidocaine hydrochloride in admixtures with eight frequently used drugs were studied. Lidocaine hydrochloride admixtures of 2 mg/ml were prepared in both glass and plastic containers of 5% dextrose injection, 0.9% sodium chloride injection, lactated Ringer's injection, 5% dextrose and lactated Ringer's injection, 0.45% sodium chloride injection (plastic container only), and 0.45% sodium chloride and 5% dextrose injection. The admixtures were examined visually and stored for 14 days at 25 +/- 0.5 degrees C under fluorescent light. Lidocaine hydrochloride concentrations were determined spectrophotometrically at times 0, 0.25, 1, 3, 8, and 24 hours, and at 24-hour intervals thereafter. Spectrophotometric assays were confirmed with high-pressure liquid chromatography. Admixtures of lidocaine hydrochloride were prepared with aminophylline, bretylium tosylate, calcium gluconate, digoxin, dopamine hydrochloride, regular insulin, phenytoin sodium, and procainamide hydrochloride in 5% dextrose injection, 0.9% sodium chloride injection, and lactated Ringer's injection. The admixtures were examined visually for 24 hours. Admixtures of lidocaine hydrochloride were stable for 14 days. All admixtures of lidocaine hydrochloride with other drugs were visually compatible except those containing phenytoin sodium. It is concluded that lidocaine hydrochloride is stable in the solutions studied for 14 days at 25 degrees C and visually compatible for 24 hours in admixtures containing all drugs studied except phenytoin sodium.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7102682

Source DB:  PubMed          Journal:  Am J Hosp Pharm        ISSN: 0002-9289


  3 in total

1.  Stability of lidocaine in aqueous solution: effect of temperature, pH, buffer, and metal ions on amide hydrolysis.

Authors:  M F Powell
Journal:  Pharm Res       Date:  1987-02       Impact factor: 4.200

Review 2.  Adverse Events Associated with Immune Checkpoint Inhibitors: Overview of Systematic Reviews.

Authors:  Salmaan Kanji; Sydney Morin; Kyla Agtarap; Debanjali Purkayastha; Pierre Thabet; Dominick Bosse; Xiang Wang; Carole Lunny; Brian Hutton
Journal:  Drugs       Date:  2022-04-13       Impact factor: 9.546

3.  Anesthetic effects and body weight changes associated with ketamine-xylazine-lidocaine administered to CD-1 mice.

Authors:  Urshulaa Dholakia; Stuart C Clark-Price; Stephanie C J Keating; Adam W Stern
Journal:  PLoS One       Date:  2017-09-14       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.